Pharma industry leaders share their expertise on Pharma Forum Dialogues, the blog launched by New York Pharma Forum in 2014. Here are the top 3 most-read blog posts of 2014.
Inter Partes Review Adds Another Twist to Hatch Waxman Litigation
Inter Partes Review is another way besides Hatch Waxman litigation to challenge a patent's validity.
By: David M. Conca, Partner, Ligitation Department and
Nao Takada, Associate, Litigation Department,
Paul Hastings LLP
Ethnic bridging studies are used to measure the impact of ethnic differences on the absorption, distribution, metabolism, or excretion of drugs.
By: Gary K. Zammit, Ph. D.,
President & CEO, Clinilabs
Pain Drug Development to Address High Unmet Needs
Pain drug development is a growing market with high unmet needs. Pharma companies are working on overcoming safety hurdles.
By: Amit Dhawan, MD, and Michael Fronstin,
Kantar Health
